Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

How US FDA And Industry Are Looking To Navigate New Supply Chain Data Reporting Requirements

Executive Summary

FDA Commissioner Hahn says industry needs to work with the agency to establish a link to more detailed supply chain information.

You may also be interested in...



US FDA’s Machine Learning Analysis Suggests Where To Look For Manufacturing Site Quality Problems

XGBoost model sees site complexity contributes to quality risk, but misses device-related issues, says third FDA pharmaceutical quality report.

Initial List Of US Essential Medicines Focuses On Acute Care

US FDA excludes chronic care products from list of medicines bolstered by domestic production investment and federal procurement requirements.

The Quality Lowdown: What Happens When The US FDA Must Choose Between Risks

Tuberculosis or cancer, sterility assurance or shortages, the choices come at you fast; Takeda, Wintac, Banco Vida updates.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS142380

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel